Christopher Worth

Withaferin A (WFA) inhibits tumor growth and metastasis by targeting ovarian cancer stem cells

Sham S. Kakar, Seema Parte, Kelsey Carter et al. · Oncotarget · 2017 · 53 citations · Full text

Cancer Management, Epidemiology Of Cancer, Pathology +24

Transcriptomic Screening of Microvascular Endothelial Cells Implicates Novel Molecular Regulators of Vascular Dysfunction after Spinal Cord Injury

Richard Benton, Melissa A. Maddie, Christopher Worth et al. · Journal of Cerebral Blood Flow & Metabolism · 2008 · 42 citations · Full text

DOXIL when combined with Withaferin A (WFA) targets ALDH1 positive cancer stem cells in ovarian cancer

Sham S. Kakar, Christopher Worth, Zhenglong Wang et al. · Journal of Cancer Stem Cell Research · 2016 · 40 citations · Full text

Withaferin A, Chemoprevention Strategy, Oncogenic Agent +13

The DXD motif is required for GM2 synthase activity but is not critical for nucleotide binding

Jia Li, David M. Rancour, Miguel L. Allende et al. · Glycobiology · 2001 · 33 citations · Full text

Two soluble glycosyltransferases glycosylate less efficiently in vivo than their membrane bound counterparts

Guofen Zhu, María L. Allende, Ewa Jaśkiewicz et al. · Glycobiology · 1998 · 30 citations · Full text